🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users injecting products of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic material and banned associated keywords and search suggestions. The organization said it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Costs

Within these groups, messages show black plastic parcels with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously seen individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious medical dangers”.